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Rodent arterial smooth muscle cells (ASMCs) express ␣ 1 -and ␣ 2 -, but not ␣ 3 -, Na ϩ pumps (39, 53, 62) . Rodent ␣ 1 -Na ϩ pumps are unusually ouabain resistant (EC 50 ϳ5 M), whereas human ␣ 1 has much higher ouabain affinity (EC 50 Ͻ20 nM), reportedly similar to that of all ␣ 2 -and ␣ 3 -Na ϩ pumps (5, 44, 57) . Indeed, nanomolar ouabain increases myogenic constriction in isolated rodent small arteries (50, 62, 65) . Prolonged (2-4 wk) infusion of low-dose ouabain induces hypertension in rodents (14, 41) , and brief infusion elevates BP in humans (42, 52) .
Mice with mutant, ouabain-resistant, but otherwise normally functional, ␣ 2 -Na ϩ pumps (13) are resistant to ouabain-induced (14) and ACTH-induced forms of hypertension (12, 38) . These effects are likely mediated by ASMC ␣ 2 -Na ϩ pumps because smooth muscle-specific reduction of ␣ 2 -Na ϩ pump expression causes BP elevation (9, 62) . In human hypertension, it is not clear whether ASMC ␣ 2 -Na ϩ pumps play a similar role because of the high ouabain affinity of human ␣ 1 (57) .
In rodents, Ϸ80% of the ASMC Na ϩ pumps have a ␣ 1 -subunit; the remainder have a ␣ 2 -subunit (53, 62) . The ␣ 2 -pumps cluster with NCX1 and receptor-and store-operated cation channels (ROCs and SOCs, respectively) in plasma membrane (PM) microdomains at PM-SR (sarcoplasmic reticulum) junctions, "plasmerosomes" (2, 26, 49, 66) . In contrast, ␣ 1 -Na ϩ pumps are widely distributed in the PM, but may be excluded from these PM microdomains (26, 27, 39, 54) . Thus NCX, ROCs, and SOCs are structurally and functionally coupled to ␣ 2 -, but not ␣ 1 -, Na ϩ pumps in rodent ASMCs (8, 31, 46, 49).
In numerous rodent hypertension models, NCX1 and TRPC6 or TRPC3 proteins (component of some ROCs) in ASMCs are markedly upregulated, and Ca 2ϩ signaling is augmented (7, 17, 35, 49, 55, 66) . Indeed, prolonged treatment of primary cultured rat ASMCs, or of normal rats, in vivo, with low-dose ouabain greatly increases arterial myocyte NCX1 and TRPC6 protein expression and Ca 2ϩ signaling mediated by NCX1 and ROCs (49) . These changes in the ASMCs are associated with the increased myogenic reactivity of small arteries, as exemplified by arteries isolated from ouabainhypertensive rats (60) and Milan hypertensive strain rats (34, 66) . Moreover, Milan hypertensive rats have elevated plasma EO levels (15, 16) . The implication is that, in rodents, the altered protein expression and enhanced Ca 2ϩ signaling in ASMCs, and the elevated BP, are all consequences of the action of EO on ␣ 2 -Na ϩ pumps. Here, we test whether similar mechanisms operate in humans. Specifically, we examine the expression and distribution of the Na ϩ pump ␣-subunit isoforms in human ASMCs (hASMCs). We also determine the effects of prolonged nanomolar ouabain treatment on the expression of some Ca 2ϩ transporters, and on Ca 2ϩ signaling in primary cultured hASMCs. The ouabain-induced changes in protein expression and Ca 2ϩ signaling in hASMCs are comparable with results obtained in rodents. This indicates that the rodents are good models for the study of these parameters and that results from the rodent studies are applicable to human arterial smooth muscle. Thus information about the linkage between salt metabolism and enhanced vascular resistance [whole body autoregulation (22) ] obtained from rodent hypertension models should be directly relevant to human salt-dependent hypertension.
MATERIALS AND METHODS
Human arteries and rodent tissues. Unused internal thoracic artery segments from coronary bypass patients were used for the experiments in Fig. 1 . Un-needed segments of distal superior mesenteric artery, adjacent to the intestinal wall (3rd or 4th order branches), from 11 brain-dead tissue donors were used for all the other studies reported here. The patients were anonymous, but included African Americans, Hispanics, and Caucasians and both men and women, ages 14 -68, with a variety of diagnoses. The arteries were obtained with informed consent. All procedures were approved by the University of Maryland School of Medicine (UMSOM) Institutional Review Board.
In a few experiments, aortae, mesenteric arteries, and whole brains from 25 to 30 g male C57BL/6 mice were harvested. Membrane proteins, prepared from the brains and de-endothelialized arteries, were used for immunoblots. Some unpublished images of primary cultured rat mesenteric artery myocytes, from a study on the effects of ouabain (49) , are also shown in RESULTS. The procedures were approved by UMSOM Institutional Animal Care and Use Committee.
Dissociation and primary culture of hASMCs. Human artery segments were placed in ice-cold, sterile HBSS (Gibco, Grand Island, NY), and the fat and connective tissue were dissected away. Each artery segment was then cut lengthwise, and the endothelium was removed by rubbing the lumenal surface with a sterile cotton-tip applicator. Artery segments that were to be used for immunoblotting were then frozen in liquid nitrogen and stored at Ϫ80°C until needed (see Immunoblot analysis of membrane proteins).
Primary cultured hASMCs were prepared using a modification of a published method (19) . The cleaned, de-endothelialized artery segments were digested for ϳ50 min at 37°C (5% CO 2-95% air) in Ca 2ϩ -and Mg ϩ -free HBSS [HBSS (2) ; Gibco] containing collagenase type 2 (1 mg/ml). The tissue was washed, the adventitia was stripped off, and segments of muscularis were stored overnight in smooth muscle cell growth medium at 37°C (Cell Applications, San Diego, CA). The next morning, the segments were cut into ϳ1-to 2-mm 2 pieces and digested for 45-50 min at 37°C (5% CO2-95% air) in HBSS(2) containing collagenase type 2 (1 mg/ml) and elastase type IV (0.5 mg/ml). The digested tissue was washed in 2 ml HBSS(2) containing 4 to 5 drops of culture medium, transferred to 2-5 ml of smooth muscle cell growth medium, and gently triturated with a flamepolished Pasteur pipette. The dissociated cells were centrifuged (1,000 g, 4°C, 5 min), resuspended in growth medium, and plated on either 25-mm coverslips in 6-well plates for immunocytochemistry or Ca 2ϩ imaging, or on 10-cm culture dishes for immunoblotting. The plated cells were maintained in growth medium under a humidified atmosphere of 5% CO 2-95% air at 37°C. The medium was changed on days 4 and 7. In cultures in which the effects of ouabain were tested, the standard growth medium was replaced by serum-free growth medium (Cell Applications) 24 h before ouabain was added. Experiments were performed on subconfluent cultures on days 8 and 9 in vitro if not indicated otherwise. Cells were confirmed as hASMCs by immunocytochemistry through cross-reactivity with antibodies directed against smooth muscle ␣-actin; a cell purity of at least 95-98% was routinely observed.
Immunoblot analysis of membrane proteins. Cultured hASMCs were harvested in PBS supplemented with protease inhibitor cocktail tablets (Roche Applied Science, Indianapolis, IN). The pellets were resuspended in lysis buffer containing 145 mM NaCl, 10 mM NaH 2PO4, 10 mM NaN3, and 1% IGEPAL supplemented with pro- 
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tease inhibitor cocktail tablets. The suspension was centrifuged (5,000 g, 4°C, 30 min). The supernate containing the extracted membrane proteins was mixed with SDS buffer containing 5% 2-mercaptoethanol, and the proteins were separated by SDS-PAGE as described (4) .
Some immunoblots were performed on membranes prepared from segments of freshly harvested, cleaned, and frozen human arteries. The frozen artery segments were pulverized with a stainless steel mortar and pestle, and membrane proteins were solubilized and separated by the same methods used for cultured hASMCs.
Mouse arteries and brains were used to compare Na ϩ pump ␣-subunit isoform expression in human and mouse tissues (Fig. 1) . Details of the methods used for the preparation of membranes from fresh rodent tissues are published (32) .
Immunoblot analysis used published methods (20, 32) . In brief, the separated proteins on the SDS-PAGE gel were blotted onto a polyvinylidene difluoride membrane, which was then cross-reacted with appropriate primary rabbit polyclonal antibodies (pAbs) and/or mouse monoclonal antibodies (mAbs). After wash, membranes were incubated with secondary anti-rabbit or anti-mouse, horseradish peroxidase-conjugated, IgG (Jackson ImmunoResearch, West Grove, PA) for 1 h at room temperature. The immune complexes on the membranes were detected by enhanced chemiluminescence-plus (Amersham BioSciences, Piscattaway, NJ) and exposure to X-ray film (Eastman Kodak, Rochester, NY). Quantitative analysis of immunoblots was performed with a Kodak DC120 digital camera and onedimensional Image Analysis Software (Eastman Kodak).
A number of primary antibodies were used for the immunoblot and immunocytochemistry studies. The pAbs directed to the peptide sequences specific to the nonhuman ␣ 1 (NASE)-, and all mammalian ␣3 (TED)-, Na ϩ pump isoforms were gifts from Dr. T. A. Pressley [Texas Tech University (47); mAb anti-NCX1 antibody (R3F1) was a gift from Dr. K.D. Philipson (University of California, Los Angeles)]. In collaboration with Dr. Pressley, we generated and tested a rabbit polyclonal antiserum directed against the human Na ϩ pump ␣1-isoform-specific peptide sequence, TSEP (47) . Rabbit pAb directed against the Na ϩ pump ␣2-specific epitope (HERED) was purchased from Millipore (Billerica, MA); anti-TRPC6 pAb was obtained from Sigma-Aldrich (PRS3897, St. Louis, MO). The following mAbs were purchased: anti-sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA2; SR Ca 2ϩ pump), anti-PMCA (PM Ca 2ϩ pump), and anti-IP3R1 (inositol triphosphate receptor-1) (all from Affinity BioReagents, ABR, Golden, CO); anti-␤-actin (Sigma-Aldrich); and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Abcam, Cambridge, MA). The anti-GAPDH and anti-␤-actin mAbs were used as immunoblot loading controls. Antibody dilutions for immunoblots were anti-NASE and anti-TSEP, 1:2,000; anti-HERED, 1:750; anti-TED, 1:750; anti-TRPC6, 1:500; anti-SERCA2, 1:1,500; anti-PMCA, 1:1,000; anti-IP3R1, 1:750; anti-GAPDH, 1:5,000; and anti-␤-actin, 1:10,000.
Immunocytochemistry. Primary cultured hASMCs were immunolabeled, as described for rodent cells (2, 66) . In a few experiments, immunocytochemistry was performed on freshly dissociated hASMCs, which were prepared using rodent ASMC protocol no. 1 (3), but with enzymatic digestion times of 50 -65 min depending upon the size of the human artery segment. The freshly dissociated cells were plated onto coverslips and permitted to settle by incubation for 4 h at 4°C. Both the cultured and the freshly dissociated cells, on coverslips, were fixed in CF fixative: 0.45% (wt/vol) formaldehyde, 75 mM cyclohexylamine, 75 mM NaCl, 10 mM EGTA, 10 mM MgCl2, and 10 mM PIPES. After fixation, the cells were permeabilized in CF fixative containing 0.5% polyoxyethylene 20 cetyl ether (Brij 58) and were then incubated overnight in antibody buffer containing one or more of the following antibodies (see above): anti-TSEP, anti-HERED, anti-NCX1, anti-SERCA2, anti-PMCA, and/or anti-TRPC6. All antibody dilutions for immunocytochemistry were 1:10. Fluorescein isothiocyanate-labeled donkey anti-mouse IgG or Cy3-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch) was used to visualize the primary antibodies. The fluorescence from the secondary antibody in the absence of primary antibody (positive control) did not exceed 2% to 3% of the fluorescence in cells cross-reacted with primary antibodies (see RE-SULTS ]CYT was measured with fura-2 by using digital imaging as described (4) . Primary cultured hASMCs were loaded with fura-2 by incubation for 40 min in smooth muscle cell growth medium containing 3.3 M fura-2-AM (20 -22°C, 5% CO 2-95% air). After dye loading, the coverslips were transferred to a tissue chamber mounted on a microscope stage, where the cells were superfused for 15-20 min (35°to 36°C) with physiological salt solution (PSS) to wash away extracellular dye. The PSS contained (in mM) 140 NaCl, 5.0 KCl, 1.2 NaH 2PO4, 5 NaHCO3, 1.4 MgCl2, 1.8 CaCl2, 11.5 glucose, and 10 HEPES (pH 7.4). In Ca 2ϩ -free PSS, the 1.8 mM CaCl 2 was omitted and 50 M EGTA was added to chelate residual Ca 2ϩ . Cells were studied for 40 -50 min during continuous superfusion with PSS (35°C).
The imaging system was based on a Zeiss Axiovert 100 microscope with a Zeiss F-Fluor 40ϫ, 1.3 NA oil immersion objective. The dye-loaded cells were illuminated with a diffraction grating-based system (Polychrome V, TILL Photonics, Munich, Germany). Fluorescent images were recorded with a CoolSnap HQ2 CCD camera (Photometrics, Tucson, AZ). Image acquisition and analysis were performed with a MetaFluor/MetaMorph Imaging System (Molecular Devices, Downingtown, PA). [Ca 2ϩ ]CYT was calculated by determining the ratio of fura-2 fluorescent emission (510 nm) excited at 380 and 360 nm as described (4, 18, 21) . Intracellular fura-2 was calibrated in situ in primary cultured hASMCs as described (4) .
Reagents. Fura 2-AM was obtained from Molecular Probes (Invitrogen Detection Technologies). Collagenase (type 2) was purchased from Worthington Biochemical (Freehold, NJ). Unless otherwise indicated, all other reagents were purchased from Sigma-Aldrich and were analytic grade or the highest purity available.
Statistical analyses. The numerical data presented in RESULTS are means Ϯ SE from n single cells (1 value per cell). Immunoblots were repeated at least three times for each protein. The number of arteries (patients) is presented where appropriate. Data from at least two patients were obtained for all protocols; in almost all cases, arteries from at least three or four patients were subjected to the same protocol. Statistical significance was determined using Student's paired or unpaired t-test, as appropriate. P Ͻ 0.05 was considered significant.
RESULTS

Expression of Na
ϩ pump ␣-subunit isoforms and several Ca 2ϩ transporters in human artery smooth muscle. A phylogenetic analysis of Na ϩ pump ␣-subunit isoforms (47) revealed that residues 489 -499 [numbering based on the rat ␣ 1 -peptide (5)] in the large cytoplasmic loop between transmembrane helices 4 and 5 contain isoform-specific, conserved peptide sequences. For example, the ␣ 2 -specific sequence, HERED, is conserved in all mammal ␣ 2 -Na ϩ pumps, and the ␣ 3 -specific sequence, TED, is conserved in all vertebrate and some invertebrate ␣ 3 -pumps. The ␣ 1 -isoform is more variable: human ␣ 1 -isoform lacks one ␣ 1 -specific peptide sequence, NASE, which is conserved in rodents and many other mammals, including dogs, guinea pigs, and opossums. Instead, human ␣ 1 and horse ␣ 1 contain the peptide sequence, TSEP, which also is not found in ␣ 2 or ␣ 3 (47).
The immunoblots in Fig. 1A verify that mouse aortae express ␣ 1 -Na ϩ pumps with a NASE, but not a TSEP, epitope, as well as ␣ 2 -Na ϩ pumps. hASMCs also express ␣ 1 -and ␣ 2 -Na ϩ pumps, but human ␣ 1 -Na ϩ pumps cross-react with antibodies raised against the TSEP epitope. Mouse brain (and human neuroblastoma cells, not shown), but neither mouse nor human arteries, expresses ␣ 3 -Na ϩ pumps (Fig. 1B) . Mouse arteries and hASMCs both express NCX1 (Fig. 1C) and TRPC6 (see next section). Smooth muscle in freshly harvested human mesenteric arteries, too, expresses ␣ 1 -and ␣ 2 -Na ϩ pumps, NCX1, and TRPC6 (Fig. 2) , as do mouse mesenteric arteries (62, 63) .
Two SR Ca 2ϩ transporter proteins examined, SERCA2 and IP 3 R1, were both expressed in primary cultured hASMCs as well as in freshly harvested arterial smooth muscle (Fig. 3) . The expression levels of all the proteins tested, when normalized to GAPDH or ß-actin expression, varied somewhat from patient to patient, in both the fresh tissues and the cultured cells. Expression of NCX1 and SERCA2, relative to ␤-actin, was greater in actively proliferating cells in media containing FBS than in growth-arrested cultures in which the FBS had been removed (Fig. 3, A and C) . An apparent increase in TRPC6 molecular weight was observed in hASMCs incubated in serum-containing growth medium, compared with the TRPC6 from freshly harvested arteries (Fig. 3B) .
It is important that data obtained in primary cultured cells from a single artery under different incubation conditions were reproducible. Thus data from hASMCs from different individuals, when subjected to the same experimental protocols, could be reliably compared. This is exemplified by the effects of prolonged incubation with low-dose ouabain (see Effects of prolonged incubation with nanomolar ouabain on Ca 2ϩ transporter expression and Ca 2ϩ signaling in hASMCs). Localization of ␣ 1 -and ␣ 2 -Na ϩ pumps in hASMCs, and association of ␣ 2 -pumps with NCX1 and TRPC6, and with the SR. In rodents, high ouabain affinity ␣ 2 -Na ϩ pumps cluster with NCX1 and ROCs in PM microdomains that overlie closely apposed, junctional SR. In contrast, low ouabain affinity ␣ 1 -Na ϩ pumps, although more widely distributed in the PM, may be excluded from the junctional PM microdomains (31) . Because human ␣ 1 -Na ϩ pumps have high ouabain affinity, it is reasonable to ask whether they have a similar distribution to ␣ 2 in hASMCs. Figures 4 -6 show that this is not the case. For example, as in rodents, ␣ 1 -Na ϩ pumps are widely distributed in the PM; they do not cluster in a reticular pattern, nor do they selectively colocalize with the SR (stained with ER tracker; Fig. 4 ). PMCA also is diffusely distributed in the PM; it, too, does not distribute in a reticular pattern and does not colocalize with the SR (Fig. 4) .
In contrast, human ␣ 2 -Na ϩ pumps, like rodent ␣ 2 -Na ϩ pumps, do cluster in reticular patterns and do colocalize with ER tracker-stained SR and with NCX1 (Fig. 5A) . Moreover, as illustrated by the confocal images of a freshly dissociated human myocyte (Fig. 6) , ␣ 2 -Na ϩ pumps colocalize with the adjacent SERCA2 at the cell surface, but only SERCA2 is found in the cell interior. These findings suggest that hASMC ␣ 2 -Na ϩ pumps may have a specialized function similar to that Numbered lanes refer to mesenteric arteries (3 rd or 4 th order branches) from 4 different patients. Anti-␤-actin served as the loading controls for all the blots. These data are representative examples from a total of 10 different patients (7 male, 3 female; 9 Caucasian, 1 Hispanic; age range ϭ 21-63 years; 6 of the 10 patients died from trauma or suicide; no patients were hypertensive). in rodents, where these pumps help to regulate Ca 2ϩ signaling by modulating NCX1-mediated Ca 2ϩ transport. TRPC6, too, colocalizes with NCX1 and ER tracker-stained SR in hASMCs (Fig. 5B) . This is consistent with a functional linkage of ROCs to NCX1 and ␣ 2 -Na ϩ pumps in rodents (34, 46, 49) .
Effects of prolonged incubation with low-dose ouabain on the viability and morphology of hASMCs.
Under control conditions, most primary cultured hASMCs had a fusiform appearance (Fig. 7A) , as expected for human cells cultured in serum-free, growth arresting medium (23, 33) . The same was true for hASMCs incubated with 10 nM ouabain in serum-free medium for 72 h, although a few cells were rounded up (arrowheads in Fig. 7B ). When the ouabain concentration was increased to 100 nM, however, many of the hASMCs died and detached from the coverslips. After 72 h, cell clusters were sparse and contained very few fusiform cells; most of the remaining cells were rounded up, with only long, thin processes extending from the nuclear region (Fig. 7C) . This is not surprising because the K D of human ␣1 Na ϩ pumps for ouabain is Ͻ20 nM (57) . A primary function of these very prevalent (housekeeper) pumps is to maintain the normally low-cytosolic Na ϩ and high-cytosolic K ϩ concentrations, [Na ϩ ] CYT and [K ϩ ] CYT , respectively (5, 20) . Thus the inhibition by ouabain should cause the cells to gain Na ϩ and water (by osmosis) and to lose K ϩ and depolarize, thereby leading to cell death. In contrast, the morphology of primary cultured rat mesenteric artery myocytes is unaffected by a 72-h incubation with 100 nM ouabain (Fig. 7, D and E 48 -72 h greatly enhances the expression and function of NCX1 and TRPC6 proteins (49) . Immunoblots of hASMCs (Fig. 8) revealed that 72-h treatment with 10 nM ouabain enhanced the expression of NCX1 by 45 Ϯ 10% (n ϭ 5 patients) and SERCA2 by 32 Ϯ 6% (n ϭ 5 patients). TRPC6 was marginally, but not significantly, increased in the hASMCs, and IP 3 R1 was not affected (Fig. 8) .
These changes in Ca 2ϩ transporter expression were reflected in altered Ca 2ϩ handling by ouabain treatment. The [Ca 2ϩ ] CYT in the quiescent (resting) cells was not significantly affected by the prior ouabain treatment (Table 1) , but agonist-evoked Ca 2ϩ signaling was significantly enhanced even though ouabain was no longer present. Figure 9A illustrates the protocol: it shows the time course of changes in [Ca 2ϩ ] CYT in two representative hASMCs from a single patient. One hASMC (red line) was from a coverslip treated with 10 nM ouabain for 72 h; the other hASMC (blue line) was from a control coverslip. The fura-2-loaded cells were first exposed to Ca 2ϩ -free medium, and 10 M ATP was then added to activate G protein-coupled purinergic receptors and promote Ca 2ϩ release from the SR (the (49) . The return to basal [Ca 2ϩ ] CYT was much slower in this case, but ATP removal before full recovery caused a rapid return to baseline. The summarized data on the cultured hASMCs from three patients are shown in the bar graphs (Fig.  9, B-D, respectively) . The 10 nM ouabain treatment increased the SR Ca 2ϩ release (indicated by the initial rise in [Ca 2ϩ ] CYT in Fig. 9A ) by 27 Ϯ 8% and augmented the Ca 2ϩ entry from the extracellular fluid by 96 Ϯ 15%, on average. 5 . Distribution of ␣2-Na ϩ pumps, NCX1, and SR in primary cultured mesenteric hASMCs. A: hASMCs were cross-reacted with anti-HERED ␣2 pAb and R3F1 anti-NCX1 mAb; the SR was then stained with ER tracker, as indicated by the labels. Insets: enlargements of the boxed areas. Pseudocolor images of the enlarged ␣2 (red) and NCX1 (green) regions, and the overlay, are shown at right. B: hASMCs were cross-reacted with R3F1 anti-NCX1 mAb and anti-TRPC6 pAb; the SR was then stained with ER tracker, as indicated. N, nuclei. Insets: enlargements of the boxed areas. Pseudocolor images of the enlarged NCX1 (green) and TRPC6 (red) regions, and the overlay, are shown at right. In A and B, the patterns of staining by both antibodies were very similar to the pattern of ER tracker (i.e., SR) distribution. Scale bars ϭ 30 m. Note that the ␣2, NCX1, and TRPC6 staining patterns are all very similar to that of ER tracker. This is reflected by the yelloworange staining in the A and B overlay panels and indicates that ␣2-Na ϩ pumps and NCX1 colocalize and overlie elements of SR.
DISCUSSION
Effects of prolonged ouabain treatment on arterial myocytes mimic in vivo changes in arteries in
pertension models (see Table 1 in Ref. 7) including the hypertension induced by prolonged (2 to 3 wk) subcutaneous infusion of ouabain in normal rats (49) . Moreover, exposure of primary cultured rodent arterial myocytes to nanomolar ouabain for 48 -72 h also increases expression of NCX1 and TRPC6 proteins (49) . In this context, it is noteworthy that plasma EO levels are significantly elevated in several rodent hypertension models (15, 16, 29) , as well as in 40 -50% of humans with essential hypertension and in most patients with aldosterone-linked hypertension (40, 43, 51) . We suggested that the increased peripheral vascular resistance in the rodent hypertension models results, in part, from the augmented Ca 2ϩ signaling and vasoconstriction as a consequence of the Ca 2ϩ transporter upregulation in the arterial myocytes (7, 34) . In this report, we address the question: Do similar mechanisms function in human arterial myocytes? The affirmative answer ap-A B C Fig. 6 . Distribution of ␣2-Na ϩ pumps and SERCA2 in a dissociated myocyte from a freshly harvested human internal thoracic artery. Myocytes were cross-reacted with anti-SERCA2 (SERCA2 mAb; A) and with anti-HERED (␣2 pAb; B) . The confocal images of a freshly dissociated hASMC are shown at left, and enlarged images of the boxed areas are shown at right. C: image overlays at low (left) and high magnification. Scale bars ϭ 5 m. Note that the ␣2 and SERCA2 staining patterns are very similar near the surface of the cell where the SR comes close to the plasma membrane (at right of low-power images), whereas only the SERCA2 mAb stains the interior of cell (at left of low-power images). This colocalization is reflected by the yellow-orange staining in the overlay panels; it indicates that the plasma membrane microdomains containing the ␣2-Na ϩ pumps overlie junctional elements of SR. Fig. 7 . Effects of prolonged incubation with 10 or 100 nM ouabain on the morphology of primary cultured human and rat mesenteric small artery myocytes. Morphology of hASMCs were cultured for 10 days in growth medium (A), or in growth medium containing 10 nM (B) or 100 nM (C) ouabain for the final 72 h of culture. In all cultures, the FBS-supplemented medium was replaced by FBS-free medium 24 h before the ouabain was added. After a 72-h incubation without or with ouabain, the cells were loaded with fura-2; the fura-2 images (360 nm excitation) are shown. Arrowheads in B and C point to some of the rounded-up cells; none are seen in A. For comparison, rat mesenteric artery myocytes cultured for 72 h without (D) or with (E) 100 nM ouabain are also shown; for details, see Ref. 49 . Scale bars ϭ 50 m.
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pears to be a critical step toward elucidating the cellular and molecular mechanisms that link the tendency to retain salt to the elevated BP in human hypertension.
Human arterial smooth muscle expresses ␣ 1 -and ␣ 2 -, but not ␣ 3 -, Na ϩ pumps. The smooth muscle in human arteries (Fig. 1) , as in rodent arteries (14, 62) , expresses ␣ 1 -and ␣ 2 -, but not ␣ 3 -, Na ϩ pumps. Both human (Fig. 2) and rodent arteries also express a number of the same Ca 2ϩ -transport proteins, including NCX1, TRPC6, SERCA2, and IP 3 R1. The expression of these Ca 2ϩ -transporters, when normalized to GAPDH or ␤-actin, appeared to vary somewhat from patient to patient. This may have been due to the fact that the recovered arteries were not anatomically identical and the patients= ages, drug treatments, and diagnoses or causes of death differed markedly. Despite these shortcomings, the immunocytochemical localization of the transporter proteins and the effects of ouabain on the cultured hASMCs were consistent from patient to patient.
The expression of these Na ϩ and Ca 2ϩ transporter proteins was usually greater in the actively proliferating, primary cultured hASMCs than in the growth-arrested myocytes (Fig. 3A) , which have reverted to a more contractile phenotype with fusiform morphology (Fig. 7A) (23, 33) . Comparable effects have been reported in rodent arterial myocyte cultures (4).
We observed an apparent increase of ϳ10 kDa in the size of TRPC6 (normally a doublet of ϳ100 kDa in nonproliferating cells) when hASMCs were cultured in complete growth medium (compare Figs. 2, 3B , and 8B; and see Ref. 4) . The explanation is uncertain, but might be due to alternative splicing and/or glycosylation (10, 64) .
NCX1 and TRPC6 colocalize with ␣ 2 -Na ϩ pumps in PM microdomains at PM-SR junctions. Immunocytochemical data from both freshly harvested, dissociated cells and primary cultured hASMCs demonstrate that ␣ 2 -Na ϩ pumps are confined to PM microdomains adjacent to elements of the SR (Figs. 5 and 6 ). The SR was identified by staining with anti-SERCA2 pAb and with ER tracker. NCX1 and TRPC6 localize to the same PM microdomains as the ␣ 2 -Na ϩ pumps.
In contrast, ␣ 1 -Na ϩ pumps and PMCA are more diffusely distributed in the hASMC PM, but whether they are excluded from the aforementioned PM microdomains is unclear. These Na ϩ and Ca 2ϩ transporter protein distribution patterns are very similar to those in rodent arterial myocytes and some other cell types (26, 31, 39, 46, 48, 54) . The implication of this structural organization, consisting of units (plasmerosomes) of PM microdomains closely opposed to junctional SR, is that the ␣ 2 -Na ϩ pumps, NCX1 and ROCs (of which TRPC6 proteins are components), and the SR are also functionally linked (8) . This is discussed in the next section.
The different distribution of the ␣ 1 -and ␣ 2 -Na ϩ pumps in hASMCs implies that they have different functions (20) . The more widely distributed ␣ 1 -pumps, which also have a higher affinity for Na ϩ (12 vs. 22 mM) (59), likely play the primary housekeeper role in maintaining the low Na ϩ and high K ϩ concentrations in bulk cytosol. The Na ϩ affinity difference is evidence not only for different roles but also for the likelihood that the Na ϩ concentration is slightly higher in the plasmerosome junctional spaces (between the PM and SR) than in the bulk cytosol. This might also help to explain why NCX1 normally operates in the Ca 2ϩ entry mode much of the time in small artery myocytes under physiological conditions (25, 62, 63) .
Prolonged incubation with nanomolar ouabain increases expression of Ca 2ϩ transporters and augments Ca 2ϩ signaling in hASMCs. Prolonged (72 h) incubation of primary cultured hASMCs with 10 nM ouabain enhanced expression of NCX1 and SERCA2 (Fig. 8) . These proteins are also upregulated in rat arterial myocytes treated with 100 nM ouabain for 48 -72 h (49) . Although TRPC6 expression, too, is enhanced by ouabain in rat myocytes (49) , this did not occur in the hASMCs (Fig. 8) . Treatment of hASMCs with 100 nM ouabain, however, damaged or killed most of the cells, presumably because all the Na ϩ pumps, both ␣ 1 and ␣ 2 , were inhibited. If human, like rodent, ␣ 2 -Na ϩ pumps have a single ouabain binding site (58) with an EC 50 of ϳ0.6 -1.0 nM (50, 61), 10 nM ouabain should have blocked 90 -95% of the ␣ 2 -pumps. A 72-h exposure to 10 nM ouabain was toxic to few hASMCs, whereas 100 nM ouabain was toxic to most of the cells (see Fig. 7 ). This suggests that human ␣ 1 -Na ϩ pumps have a lower affinity for ouabain (EC 50 on the order of 10 -20 nM) than do human ␣ 2 -pumps, albeit not nearly as low as the affinity of rodent ␣ 1 -pumps for ouabain (EC 50 ϳ5 M). With this difference in ␣ 1 -and ␣ 2 -Na ϩ pump ouabain affinity, we might expect circulating levels of EO in humans, in the range of 0.1-0.35 nM (56), to modulate ␣ 2 -Na ϩ pump activity and, through NCX1, Ca 2ϩ signaling, with negligible effect on ␣ 1 .
The augmentation of ATP-evoked SR Ca 2ϩ release in hASMCs cultured with 10 nM ouabain for 72 h (Fig. 9) correlates with the increased NCX1 and SERCA2 expression in these cells (Fig. 8) and with the colocalization of these transporters with ␣ 2 -Na ϩ pumps at plasmerosomes (Figs. 5 and 6). The implication is that the prolonged interaction of ouabain with ␣ 2 -Na ϩ pumps upregulates NCX1 and SERCA2 expression. Then, because NCX1 operates primarily in the Ca 2ϩ entry mode in arterial myocytes under physiological conditions (25, 62, 63) (Table 1) , but it enables enhanced Ca 2ϩ release (and, presumably, vasoconstriction) when the myocytes are activated, e.g., by ATP (Fig. 9) .
The increased Ca 2ϩ entry, in the ouabain-treated cells, when external Ca 2ϩ is restored in the continued presence of ATP (Fig. 9) , is likely mediated by ROCs and SOCs (49) . The ROCs should be activated by ATP-induced diacylglycerol synthesis, whereas the SOCs should be opened as a consequence of the SR Ca 2ϩ store depletion. Ca 2ϩ entry through L-type voltagegated Ca 2ϩ channels is probably not involved under these conditions because the hASMCs should not be depolarized.
It is important to distinguish these slowly developing (longterm) mechanisms by which ouabain augments Ca 2ϩ signaling in arterial myocytes from the short-term mechanisms by which acutely applied nanomolar ouabain elevates the sub-PM Ca 2ϩ concentration and rapidly increases vascular tone (50, 61) . Both mechanisms utilize some of the same molecular machinery, including ␣ 2 -Na ϩ pumps and NCX1, but the long-term mechanisms discussed in this report involve gene transcription and protein expression and, perhaps, other mechanisms such as protein phosphorylation. The details of how ouabain/EO triggers the process are unknown but might involve ouabain/Na Table 1 (patients 1-3). The expression of ␣1-and ␣2-Na ϩ pumps, NCX1 and TRPC6, in the smooth muscle from the freshly harvested mesenteric arteries of patients 2 and 3 of Fig. 2 correspond to patients 1 and 2, respectively, in this figure and in Table 1. direct effects of ouabain on cation transport (36, 37) . It is interesting that upregulation of these same Na ϩ and Ca 2ϩ transporter mechanisms has been implicated in many different types of experimental hypertension (1, 7, 17, 34, 55, 66) . The final common path in the pathogenesis of hypertension. The main conclusion from these studies is that the same ouabain-dependent long-term mechanisms that augment Ca 2ϩ signaling and vascular tone in rodent arterial myocytes (49) are also functional in human arterial myocytes. The implication is that in human hypertension, including a large fraction of patients with essential hypertension and those with hypermineralocorticoid syndromes, in whom plasma EO is elevated (40, 43, 51) , these Na ϩ and Ca 2ϩ transport mechanisms promote the increased vascular tone. They also augment responses to (enhanced) sympathetic drive and to humoral vasoconstrictors and, thereby, elevate BP. We suggest that these molecular/ cellular mechanisms are responsible for the whole body autoregulation (22) that increases peripheral vascular resistance and enhances vascular contractility, hallmarks of chronic hypertension (11) . Indeed, the structural remodeling that is often described in chronic hypertension may be triggered by these functional and molecular changes (7) .
